CASI Pharmaceuticals
CASI
#10174
Rank
A$28.81 M
Marketcap
A$1.40
Share price
10.85%
Change (1 day)
-71.31%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): A-$3.99

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$3.93. In 2024 the company made an earnings per share (EPS) of A-$3.84 a decrease over its 2023 EPS that were of A-$3.03.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$3.993.85%
2024A-$3.8426.73%
2023A-$3.03-32.89%
2022A-$4.5111.9%
2021A-$4.03-38.44%
2020A-$6.55-8.96%
2019A-$7.2050%
2018A-$4.8077.78%
2017A-$2.705.88%
2016A-$2.55-22.73%
2015A-$3.30-76.09%
2014A-$13.80318.18%
2013A-$3.30-71.79%
2012A-$11.7065.96%
2011A-$7.05-50%
2010A-$14.10-18.97%
2009A-$17.40-63.64%
2008A-$47.843.57%
2007A-$46.19-60.56%
2006A-$117.1397.22%
2005A-$59.39-2.7%
2004A-$61.04-45.59%
2003A-$112.19-61.8%
2002A-$293.66-25.52%
2001A-$394.30-21.38%
2000A-$501.5313.86%
1999A-$440.49149.53%
1998A-$176.5398.15%
1997A-$89.0910.2%
1996A-$80.84